Correlation Between Salarius Pharmaceuticals and Nutriband

Can any of the company-specific risk be diversified away by investing in both Salarius Pharmaceuticals and Nutriband at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salarius Pharmaceuticals and Nutriband into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Salarius Pharmaceuticals and Nutriband, you can compare the effects of market volatilities on Salarius Pharmaceuticals and Nutriband and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salarius Pharmaceuticals with a short position of Nutriband. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salarius Pharmaceuticals and Nutriband.

Diversification Opportunities for Salarius Pharmaceuticals and Nutriband

0.11

Correlation Coefficient

Salarius Pharmaceuticals  Nutriband

Average diversification

The 3 months correlation between Salarius and Nutriband is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Salarius Pharmaceuticals and Nutriband in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nutriband and Salarius Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salarius Pharmaceuticals are associated (or correlated) with Nutriband. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nutriband has no effect on the direction of Salarius Pharmaceuticals i.e., Salarius Pharmaceuticals and Nutriband go up and down completely randomly.

Pair Corralation between Salarius Pharmaceuticals and Nutriband

Given the investment horizon of 90 days Salarius Pharmaceuticals is expected to generate 3.18 times less return on investment than Nutriband. But when comparing it to its historical volatility, Salarius Pharmaceuticals is 1.14 times less risky than Nutriband. It trades about 0.01 of its potential returns per unit of risk. Nutriband is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  471.00  in Nutriband on September 2, 2024 and sell it today you would earn a total of  9.00  from holding Nutriband or generate 1.91% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Salarius Pharmaceuticals  vs.  Nutriband

Salarius Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Salarius Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Salarius Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Nutriband

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Nutriband are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Nutriband sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Salarius Pharmaceuticals and Nutriband

The main advantage of trading using opposite Salarius Pharmaceuticals and Nutriband positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salarius Pharmaceuticals position performs unexpectedly, Nutriband can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nutriband will offset losses from the drop in Nutriband's long position.

The idea behind Salarius Pharmaceuticals and Nutriband pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.